• The company is incorporated in England and Wales and its main country of operation is the UK
• There are no other exchanges or trading platforms on which the Company has applied or agreed to have any of its securities (including its AIM securities admitted or traded)

Business Description

Imperial Innovations combines the activities of technology transfer, company incubation and an early stage venture capital fund. The company's investment strategy is to invest in early to late stage opportunities from a broad spectrum of sectors including healthcare, energy and environment, software & IT and engineering. Investments originate from Imperial College or other research organisations including universities, government laboratories and industry.

Board Committees

The Board has delegated certain of its functions and responsibilities to the following Committees of the Board

The Remuneration Committee

Dr David Allen (Chairman)
Dr Martin Knight,
Mr Mark Rowan.

Download the Remuneration Committee terms of reference

The Audit Committee

Mr Mark Rowan (Chairman),
Dr Paul Atherton

Download the Audit Committee terms of reference

The Nomination Committee

Dr Martin Knight (Chairman),
Dr Paul Atherton
Mr Mark Rowan

Download the Nomination Committee terms of reference

Notice of AGM

The Imperial Innovations Group plc Annual General Meeting will be held at The Imperial Incubator, Bessemer Building, Imperial College London SW7 2AZ at 11.30 a.m. on 15 December 2009

Download documentation

Articles of Association

Download the Articles of Association

Shares in Issue

The number of AIM securities in issue is 59,790,621. No AIM securities are held as treasury shares.

So far as Imperial Innovations Group plc is aware, the percentage of AIM securities in issue that is not in public hands is 91.01%

Significant shareholders and percentage holdings

There are no restrictions on the transfer of the Company's AIM securities

Financial Statements

Notifications made by the company

Advisors